Muscle Relaxants Flashcards

1
Q

Acetylcholine

Neurotransmitter at NMJ

Formation
 ________ + ________ ( enyzme
_________________ ) → Ach

Destruction
 Action of ________ present in ________

A

Choline + acetyl co A

choline acetyl transferase

acetyl cholinesterase

synaptic cleft

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Neuromuscular Transmission :

Depolarisation of motor nerve→ ____ propagated to _______→↑permeability to ________ & ________ of vesicles→Ach release

Ach cross synaptic cleft & bind to receptors →Dep. of _________________ & generation of AP →_____ channels open→_____ release→ _______ + _________ coupling → CONTRACTION

A

AP; NMJ; calcium; exocytosis

muscle end plate; Na; Ca

actin + myosin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Factors which influence NMT

Prevent Ach SYNTHESIS
_______________

Prevent Ach RELEASE
_______________, _______________, ____________, _______________

Deplete Ach STORES

______________

A

Hemicholinium

↓calcium, ↑magnesium Botulism Aminoglycosides

Tetanus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Factors which influence NMT

Block Ach RECEPTORS
_______,________________

Block action of acetyl- cholinesterase
_______________,______________

A

Muscle relaxants Myasthenia gravis

Anticholinesterases

Organophosphorus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are Muscle Relaxants?

Drugs used to impair _______________ and used to provide skeletal muscle _________ during anaesthesia or critical care.

A

neuromuscular transmission

relaxation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Indications for Muscle Relaxants :

To Facilitate :
_________
__________
____________

A

Tracheal intubation
Ventilation
Surgical access

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Classification

DEPOLARISING MR ( Competitive or Non-Competitive?))

Resemble Ach →bind to receptors → _____________ (_____________)

Not metabolised by _____________.

Concentration in synaptic cleft remains high.
Reversal by _____________ from ________ & ___________ by _____________ Phase ___ block
No ___________
No _____________

A

Non-Competitive

initial depolarisation ; fasiculations

acetylcholinesterase ; diffusion ; NMJ

Hydrolysis ; pseudocholinesterase Phase I

fade; post tetanic potentiation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Depolarizing Block

Because _______ resembles Ach it stimulates the receptors first causing _________

•It then stays fixed on receptors as it is not metabolised by ____________.

•It therefore prevents Ach from reacting with the receptors and allowing NMT.

A

suxamethonium; fasiculations

acetylcholinesterase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

NON DEPOLARISING MR(Competitive or Non-Competitive?)

Bind to Ach receptors (with or without?) initial depolarisation; (fasciculation or no fasiculations?) .
Phase ___ block

Exhibit ______
Exhibit _______________

A

Competitive ; without

II; fade; post tetanic potentiation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Non-Depolarising MR

Reversal- redistribution, metabolism, excretion.

_______________ - inhibits ______________→ ↑ Ach.

Potentiated by __________,__________ agents, (alkalosis or acidosis?) , ↓ K, ↑ Mg, ↓ Ca.

A

Anti cholinesterase; acetyl cholisterase

aminoglycosides ; volatile

Acidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Monitoring the NMJ Peripheral nerve stimulator
Assess _______ , _______, _______ or _______ response to electrical stimulus.

Use _______, _______ or _______ nerve

A

visual, tactile, mechanical or EMG

ulnar, facial or tibial nerve

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Monitoring the
Patterns of stimulation.

Single twitch (_____ – ______ Hz).

Tetanic stimulation (____ - ____ Hz. x ______ s)

Post tetanic stimulation using single twitches
Train of four —____ twitches at ____ hz.

A

0.1 – 1.0 Hz

50 - 100 Hz. x 3- 5s

4 twitches at 2 hz.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Train of Four (TOF) twitches:

Only 3 twitches → ____% block
Only 2 twitches → ____%
Only 1 twitch → ____%
No twitch →____%

A

75% ; 80% ; 90% ; 100%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Train of Four (TOF) twitches:

____ % reqd for intubation
____ –____% for maintenance
___ –____% before attempting reversal

A

100
90-100
75-80

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Train of Four (TOF) twitches:

100 % reqd for __________
90 –100% for __________
75 –80% before __________

A

intubation
for maintenance
before attempting reversal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

BefORE MR(NO BLOCK)

No MR given, Ach crosses NMJ and stimulates the receptors causing NMT •Nerve stimulator produces ______ twitches
•Also applicable to ________ of ________

A

full

reversal of NDMR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

After MR (Complete block)

•NDMR blocks the Ach receptors and prevents further NMT
•Nerve stimulator produces ______ twitches on stimulation
•__________ can be carried out.

A

no; Intubation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Partial Block

•NDMR gets ______________ and few Ach molecules can now stimulate the receptors •Nerve stimulator produces __________ amplitude.

A

metabolised

reduced twitch

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

FADE

With a partial block- _____ MR show a _________↓ amplitude – No fade

•With a partial block- ________ MR show a __________ ↓ in amplitude from the 1st to the 4th twitch in a TOF - Fade

A

Dep; uniform

non-dep; gradual

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Post-Tetanic Facilitation

With a partial _______ block, tetanic stimulation recruits Ach molecules to
the synaptic cleft
•Subsequent twitches have __________ – Post tetanic facilitation/stimulation

A

non-dep; ↑amplitude

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Suxamethonium

Clinical Practice in 1951
____ Ach molecules

Dose
_______ mg/kg ____
____ mg/kg ___/____

Onset: __________
Indicated in (slow or rapid?) sequence induction
Duration ________________

A

2

1–2; I.v
2; I.m/s.c

30-45 secs; rapid

2 –5 mins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Suxamethonium

Best for anticipated ________________

A

difficult intubation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Suxamethonium

CVS - _____cardia
More frequent in (children or adults?)and with a ______ dose given within ________.

MSS - ________ → Postoperative __________

↑ ————-,______,__________ pressures

Hyperkalaemia-↑K by 0.5meq/L x3–5 mins
↑with _________ injuries , ______

A

Brady; children; 2nd ; 5 mins

Fasiculations; myalgia

Intragastric, intraoccular, intracranial

Denervation; burns

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Suxamethonium

Can cause ________________, a
Premonitory sign of ________________

Myoclonus
Adverse drug reaction

A

Malignant hyperthermia

masseter spasm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Suxamethonium is metabolised by ______________ which has a reduced Conc in : ?????(list 4)

A

pseudo- cholinesterase

Pregnancy
- Liver disease,
- Malnutrition,
- ↓ protein states

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Pseudocholinesterase

Inhibitors
- ___________
- ___________
- ___________

Results in ____________

A
  • Ecothiopate
  • Phenelzine
  • Trimetaphan

prolonged apnoea

27
Q

Dibucaine Number

Normal DN ____-____%

Heterozygous DN ______% -apnoea x _________ min
Homozygous DN _________% - apnoea x _________

A

75–85

40-60; 10 – 20

15-25; 6-8 hours

28
Q

Non-depolarising MR

CLASSIFICATION

________________
_____________________

A

Benzylisoquinolines

Aminosteroids -Vagolytic

29
Q

Non-depolarising MR

CLASSIFICATION
Benzylisoquinolines -Release __________

Examples : __________ , __________, __________ __________

A

Histamine

Atracurium ,Cis-atracurium, Mivacurium Doxacurium

30
Q

Non-depolarizing MR

Aminosteroids -Vagolytic
_____________ , _____________, _____________,

_____________

A

Pancuronium, Vecuronium Pipecuronium,
Rocuronium

31
Q

Non-depolarizing MR

There’s a

_________ dose for intubation , and ____________ dose (which is ________ of _________ dose)

A

Loading; intubation

Maintenance; 1⁄3 -1⁄4

loading

32
Q

Atracurium :

1980
Solution stored at _______oC

Dose
Loading dose -____mg/kg
Maintenance- _____-______
Infusion ___-____ mcg/kg/min
Onset ____-_____ mins
Duration ________ mins

A

2 – 8

0.5 ; 1/3 – 1⁄4

5-10

1.5 – 2

20 - 30

33
Q

Atracurium

Effects

_____________
_______________

A

CV stability
Bronchospasm

34
Q

Atracurium

Metabolism
•____________ degradation 50-60% (____________ dependent, ____________ but ________ and _________ dependent)

• _________________

A

Hoffman’s degradation ; Non organ dependent

Non enzymatic ; pH and temp dependent

Ester hydrolysis

35
Q

Laudanosine - Product of ____________, can cause _______________ & _________ especially in ________ failure.

A

Hoffman metab.

CNS excitability ; Seizures; liver

36
Q

Cis-Atracurium

___________ of atracurium

DOSE - ____-_____mg/kg
ONSET - _____-______
DURATION – _____-______

A

Isomer

0.1 – 0.2

1.5 –2 mins

30 – 40 mins

37
Q

Cis-Atracurium

EFFECTS
____________ release
____________

METAB -70 – 80 % __________
(More or Less?) ____________ produced as less total dose used.

A

No histamine; CV stability

Hoffmans; less

laudanosine

38
Q

Mivacurium

1993
Mivacurium
DOSE - _____ – _____ mg/kg
ONSET –_____ –_____ mins
DURATION –_____ – _____ mins

A

DOSE - 0.15 – 0.2 mg/kg
ONSET –1.5 –2 mins
DURATION –10 – 20 mins

39
Q

Mivacurium

EFFECTS
_____________

(Small or Large?) dose given rapidly → ________ release.

METAB - _______________________.

A

CV stability

Large

histamine

Plasma cholinesterase

40
Q

Alternative to suxamethonium especially in paeds is ???

A

Mivacurium

41
Q

Doxacurium :
1991
DOSE - _______ mg/kg
ONSET – ______ mins.
DURATION - _____________.

A

1991
DOSE - 0.05 mg/kg
ONSET – 4- 5 mins.
DURATION - 1-3 hours.

42
Q

Doxacurium :

EFFECTS
____________ release.
_____________

METAB
(Slow or Fast?) hydrolysis by _____________.

Excreted (changed or unchanged?) by liver and kidneys.

USES - ____________ surgery-neuro, cardio.

A

No histamine; CV stability

Slow ; plasma cholinesterase

Unchanged; Prolonged

43
Q

Pancuronium :
1967
________________ compound.

DOSE – _____ – _____ mgkg
ONSET – _____ –_____ mins.
DURATION – _____ – _____ mins.

A

Bisquartenary amino- steroid

DOSE – 0.08 – 0.1mgkg
ONSET – 2 – 3 mins.
DURATION – 40 – 60 mins.

44
Q

Pancuronium

EFFECTS
___________ / ___________
↑ ____, _____, _____.

Useful in _______
Caution in ___________ or ___________ dx

A

Vagolytic / Sympathomimetic

↑ HR, BP, CO.

shock

hypertension ; Ishaemic Heart dx

45
Q

Pancuronium

METAB
By the ______ with _______ excretion
Presence of __________________, so caution in ________________

A

Liver; renal

Active metabolites

renal dysfxn.

46
Q

Vecuronium

1983
Comes as _________
DOSE -____ – ____mg/kg
ONSET - _____ mins.
DURATION -_________ mins
EFFECTS - ________________
METAB – 75% _______. 25% _______ . ______ admin.

A

powder

0.08; 0.12 ; 1.5; 20 – 30

CV stability; biliary; renal

ICU

47
Q

Pipecuronium :
1990
DOSE – ______ – ______ mg/kg
ONSET – ______ – ______ mins.
DURATION - ______ – ______ mins.

A

0.06 – 0.1mg/kg

2.5 – 3 mins.

90 – 120 mins.

48
Q

Pipecuronium

EFFECTS - ___________
METAB - 70% _______ . 30% _______.

A

CV stability

Renal

Biliary

49
Q

Rocuronium :

1994

DOSE – ______ – _____ mgkg
ONSET - _______.
DURATION – _____ – ____ mins.

A

DOSE – 0.45 – 0.6 mgkg
ONSET - 60 secs.
DURATION – 30 – 40 mins.

50
Q

Rocuronium

METAB. – Eliminated _________ by liver.
Reversed by __________

A

unchanged

Sugammadex

51
Q

_______________ Can replace suxamethonium for rapid sequence induction

A

Rocuronium

52
Q

Sugammadex can be given immediately after rocuronium

T/F. With scenario

A

T

16mg/kg

e.g in cases of failed intubation

53
Q

Further classification of MRs
ONSET
Rapid – ___________,___________
Intermediate- ______,______,________,________,__________

Delayed – ____________.

A

Suxamethonium (30s), Rocuronium (60s)

Atracurium, Mivacurium, Pancuronium, Pipecuronium,Vecuronium.

Doxacurium

54
Q

Further Classification of MRs

DURATION
Ultra- short - ___________
Short acting – ____________.
Intermediate – __________, __________, __________.
Long - __________, __________, __________.

A

Ultra- short - Suxamethonium
Short acting – Mivacurium.
Intermediate – Atracurium, Vecuronium, Rocuronium.
Long - Pancuronium, Doxa, Pipe.

55
Q

Reversal :

________________/________________
 Reversibly bind to enzyme leading to deactivation → ↑ Ach conc at NMJ → ↑ Ach at Nicotinic and Muscarinic Sites.
 ______________

A

Acetylcholinesterase Inhibitors /Anti Cholinesterase.

Neostigmine

56
Q

_______________- can reverse rocuronium

A

Sugammadex

57
Q

Effects Of Anticholinesterase:

______cardia
______________
↑ __________
CNS ________
↑ _________
↑ Glandular secretions.

Muscarinic effects antagonised by _____________

A

Brady; Bronchospasm

Secretions; agitation

Peristalsis; anticholinergics

58
Q

Muscarinic effects antagonised by anticholinergics - _________,________.

A

Atropine

Glycopyrrolate

59
Q

Effects Of Anticholinesterase:

Neostigmine- ______ mg/kg.
_____-_____ mg max.

Atropine - ____mg/ 1 mg neostigmine. Glycopyrrolate -_____ mg/ 1 mg neostigmine.

A

0.04

2.5 – 5

0.5 ; 0.25

60
Q

In reversal, Anticholinergics given after neostigmine

T/F

A

F
Anticholinergics given before or with Neostigmine BUT never after

61
Q

Clinical Assessment of Reversal:

Sustained _________ x ____ secs → < 30% blk

Ability to
___________
___________
___________
Maintain sustained ___________.
Achieve adequate ______ - look at the reservoir bag
Achieve adequate ______- 15mls/kg.
Achieve inspiratory press _____cmH2O

A

head lift x 5 secs
Open mouth.
Protrude tongue.
Cough
hand grip.
VT
VC
20cmH2O

62
Q

D-Tubocurarine :

1935
_____________ compound.
Dose _____ – _____mg/kg.
Onset ___-____ mins.
Duration – ____-____mins.

A

Dose 0.5 – 0.6 mg/kg.
Onset 3 – 5 mins.
Duration – 30 - 50 mins.

63
Q

D-Tubocurarine :

Effects –
Histamine release +++ →Broncho______
- Vaso________. - ____tension

________ blockade.
Severe _______________.

Metabolism. - Excreted unchanged by _______.
Uses - ______________ anaesthesia.

A

spasm.; dilatation; Hypo

Ganglion; anaphylaxis

kidneys

Hypotensive